Atlas Capital Advisors LLC Decibel Therapeutics, Inc. Transaction History

Atlas Capital Advisors LLC

  • $656 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
BUY
$2.76 - $5.23 $41,400 - $78,450
15,000 Added 60.0%
40,000 $36.4 Million
Q2 2022

Aug 16, 2022
SELL
$1.85 - $4.21 $29,646 - $67,465
-16,025 Reduced 39.06%
25,000 $105 Million
Q3 2021

Oct 28, 2021
BUY
$6.6 - $9.04 $153,298 - $209,972
23,227 Added 130.5%
41,025 $316,000
Q2 2021

Jul 30, 2021
BUY
$6.39 - $11.51 $113,729 - $204,854
17,798 New
17,798 $153,000

About Decibel Therapeutics, Inc.

DBTX Quotes by TradingView
  • Ticker DBTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 24,964,500
  • Description
  • Decibel Therapeutics, Inc., a clinical-stage biotechnology company, engages in discovering and developing transformative treatments for hearing and balance disorders. Its product candidates and programs focuses on three areas, such as Gene Therapies for Congenital, Monogenic Hearing Loss designed to restore functional cells within the cochlea to...
More about DBTX
Track This Portfolio

Track Atlas Capital Advisors LLC Portfolio

Follow Atlas Capital Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atlas Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Atlas Capital Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email